ANAPTYSBIO INC (ANAB)
US0327241065 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -163.30M | -163.62M | -128.72M | -57.80M | -19.93M | |||
| Depreciation Amortization | 645.00K | 652.00K | 680.00K | 620.00K | 560.00K | |||
| Change In Working Capital | -15.82M | -324.00K | 6.84M | -7.49M | -6.77M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 44.98M | 42.49M | 47.62M | 18.75M | 11.99M | |||
| OPERATING CASH FLOW | -133.48M | -120.80M | -73.59M | -45.92M | -14.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -654.00K | -807.00K | -360.00K | -1.37M | -570.00K | |||
| Other Investing Activity | 128.63M | 145.56M | -394.49M | 40.20M | 95.04M | |||
| INVESTING CASH FLOW | 127.97M | 144.75M | -394.85M | 38.84M | 94.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | -1.38M | |||
| Stock Issued/Repurchased | -10.46M | -47.53M | 11.83M | 2.55M | 500.00K | |||
| Other Financing Activity | -24.90M | -11.77M | 32.19M | 249.75M | 0.00 | |||
| FINANCING CASH FLOW | -35.36M | -59.30M | 44.02M | 252.30M | -880.00K | |||
| CHANGE IN CASH | -40.87M | -35.34M | -424.42M | 245.22M | 79.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -133.48M | -120.80M | -73.59M | -45.92M | -14.16M | |||
| Capital Expenditure | -654.00K | -807.00K | -360.00K | -1.37M | -570.00K | |||
| FREE CASH FLOW | -134.14M | -121.61M | -73.95M | -47.29M | -14.73M | |||
All data in USD